Adaptimmune Therapeutics Plc Revenue per Employee (ADAP), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Adaptimmune Therapeutics Plc  (NASDAQ: ADAP)
 

Adaptimmune Therapeutics Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Adaptimmune Therapeutics Plc's Revenue per employee fell on a trailing twelve month basis to $ 264,573, but the productivity of Adaptimmune Therapeutics Plc's employees remained above the company average.
Within the Healthcare sector Employees of 348 other companies have achieved higher revenue per employee. While Adaptimmune Therapeutics Plc's total ranking has deteriorated compared to the previous quarter from 0 to 2720. Adaptimmune Therapeutics Plc has 246 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADAP Revenue per Employee (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Revenue Change -89.33 % 28.3 % 1294.81 % 458.83 % 2399.63 %
Sales per Employee (TTM) $ 264,573 730,240 723,707 711,549 575,037
ADAP's Total Ranking # 2720 # 0 # 0 # 1141 # 0
Seq. Revenue Change 87.74 % 126.1 % -92.12 % -68.1 % 2158.38 %

ADAP Company Profile >> Back to ADAP Efficiency Comparisons >> Compare ADAP Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 44
Healthcare Sector # 349
Overall Market # 2720

Revenue per Employee Statistics
High Average Low
$ 730,240 $ 187,448 $ -155,248
(Mar 31 2025)   (Dec 31 2019)



Financial Statements
Adaptimmune Therapeutics Plc's Revenue MRQ $ 14 Millions Visit ADAP's Income Statement
Adaptimmune Therapeutics Plc's Revenues TTM $ 65 Millions Visit ADAP's aggregate revenue growth
What are ADAP's Sales? Visit ADAP's Sales by Segment




Other Ratios
Adaptimmune Therapeutics Plc's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ADAP's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ADAP's Competitors
Revenue per Employee for ADAP's Suppliers
Revenue per Employee for ADAP's Customers

You may also want to know
ADAP's Sales Growth Rates ADAP's Pe Price to earnings ratio ADAP's Receivables Turnover Ratio ADAP's Stock Quote
ADAP's Net Income Growth Rates ADAP's Ps Price to Sales ratio ADAP's Sales per Employee ADAP's Asset Turnover Ratio
ADAP's Net Margin ADAP's Pb Price to Book ratio ADAP's Financial Strength Ratios ADAP's Dividend Payout Ratio
Date modified: 2026-06-23T20:00:26+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2025Number of Employees Jun 30 2025
Zimmer Biomet Holdings Inc   460,811.76 $ 7,833.800  Million 17,000 
Angiodynamics Inc   459,881.33 $ 290.645  Million 632 
Inogen Inc   456,138.11 $ 343.472  Million 753 
Assembly Biosciences Inc   455,438.36 $ 33.247  Million 73 
Airsculpt Technologies Inc   454,845.73 $ 165.109  Million 363 
Teladoc Health Inc   453,976.43 $ 2,542.268  Million 5,600 
Elanco Animal Health Incorporated  452,929.29 $ 4,484.000  Million 9,900 
Cumberland Pharmaceuticals Inc   452,385.09 $ 42.072  Million 93 
Resmed Inc   449,777.48 $ 5,113.970  Million 11,370 
Inmed Pharmaceuticals Inc  449,327.27 $ 4.943  Million 11 
Mimedx Group Inc   448,282.18 $ 362.212  Million 808 
Editas Medicine Inc   447,149.43 $ 38.902  Million 87 
Caredx Inc   445,524.18 $ 340.826  Million 765 
Ultragenyx Pharmaceutical Inc   445,046.68 $ 610.159  Million 1,371 
Haemonetics Corporation  445,014.22 $ 1,345.278  Million 3,023 
Delcath Systems Inc   443,634.62 $ 69.207  Million 156 
Globus Medical Inc   437,743.50 $ 2,626.461  Million 6,000 
Insulet Corporation  436,944.44 $ 2,359.500  Million 5,400 
Arcus Biosciences Inc   435,940.10 $ 262.000  Million 601 
Rosecliff Acquisition Corp I  435,692.31 $ 28.320  Million 65 
Cormedix Inc   435,649.01 $ 83.209  Million 191 
Nephros Inc   432,583.33 $ 15.573  Million 36 
Interpace Biosciences Inc   426,156.86 $ 43.468  Million 102 
Stryker Corp  425,321.43 $ 23,818.000  Million 56,000 
Strata Critical Medical Inc   423,196.34 $ 254.341  Million 601 
Quidelortho Corp  421,784.62 $ 2,741.600  Million 6,500 
Neuropace Inc   421,444.98 $ 88.082  Million 209 
Cryo cell International Inc   420,905.04 $ 31.989  Million 76 
Regenxbio Inc   419,897.57 $ 155.782  Million 371 
Solventum Corporation  419,400.00 $ 8,388.000  Million 20,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.